免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA PMA

脉冲发生器,起搏器,植入式,具有心脏再同步(CRT-P)

PMA编号:P030005 · 2026-07-23

申请人Guidant Corp.
决定日期2026-07-23
PMA 编号P030005
产品代码NKE
设备分类第3类
医疗专科U
咨询委员会CV 请注意,由于原文未提供具体内容,以下是一个示例翻译: --- 产品名称:[产品名称] 公司名称:[公司名称] FDA批准号:[FDA批准号] 510(k)申请号:[510(k)申请号] PMA申请号:[PMA申请号] 临床试验注册号:[NCT] PubMed ID:[PMID] 产品标识符:[标识符] 产品URL:[URL] --- 请将上述示例中的[产品名称]、[公司名称]、[FDA批准号]等占位符替换为实际内容。

器械摘要

Pulse generator, pacemaker, implantable, with cardiac resynchronization (CRT-P) is the device name listed in this FDA 510(k) record. The listed applicant is Guidant Corp.. It received FDA 510(k) clearance on 2026-07-23. The device is classified under product code NKE. It was reviewed by the CV advisory panel.

常见问题

What is the Pulse generator, pacemaker, implantable, with cardiac resynchronization (CRT-P)?

Pulse generator, pacemaker, implantable, with cardiac resynchronization (CRT-P) is a medical device that received FDA 510(k) clearance on 2026-07-23. The listed applicant is Guidant Corp..

When did Pulse generator, pacemaker, implantable, with cardiac resynchronization (CRT-P) receive FDA 510(k) clearance?

The clearance date for Pulse generator, pacemaker, implantable, with cardiac resynchronization (CRT-P) can be found in the official FDA records.

脉冲发生器、心脏起搏器、植入式、具有心脏再同步(CRT-P)功能的设备,列出的申请人是谁?

The FDA 510(k) record lists Guidant Corp. as the applicant. This does not by itself establish the device manufacturer.

FDA脉冲发生器、心脏起搏器、植入式、具有心脏再同步(CRT-P)的产品代码是什么?

FDA产品代码为脉冲发生器、起搏器、植入式,具有心脏再同步(CRT-P)功能的为NKE。

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑